Planet 13 Holdings (PLNH) Profit After Tax (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Profit After Tax of -$8.1 million for Q1 2026, down 22.43% year-over-year from -$10.4 million in Q1 2025, and down 48928.72% quarter-over-quarter from $16580.0 in Q4 2025.
Planet 13 Holdings (PLNH) Profit After Tax (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Profit After Tax for 6 consecutive years, with -$8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 22.43% year-over-year to -$8.1 million; the TTM figure through Mar 2026 stood at -$56.2 million (down 40.67% YoY), while the FY2025 annual figure was -$59.3 million, down 24.04% from the prior year.
- Profit After Tax fell to -$8.1 million in Q1 2026 per PLNH's latest filing, from $16580.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $16580.0 in Q4 2025 and bottomed at -$46.3 million in Q3 2023.
- Historically, Profit After Tax has averaged -$13.1 million across 5 years, with a median of -$6.6 million in 2025.
- On a YoY basis, Profit After Tax climbed as much as 100.06% in 2025 and fell as far as 1140.68% in 2025.
- Planet 13 Holdings' Profit After Tax stood at -$42.1 million in 2022, then jumped by 78.21% to -$9.2 million in 2023, then tumbled by 188.31% to -$26.4 million in 2024, then surged by 100.06% to $16580.0 in 2025, then tumbled by 48928.72% to -$8.1 million in 2026.
- Business Quant data shows PLNH's Profit After Tax at -$8.1 million in Q1 2026, $16580.0 in Q4 2025, and -$41.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Planet 13 Holdings | 46.72 Mn | 30.24 Mn | 12.32 Mn | -5.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.59 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 16,580.00 |
| Sep 30, 2025 | -41.25 Mn |
| Jun 30, 2025 | -6.83 Mn |
| Mar 31, 2025 | -6.61 Mn |
| Dec 31, 2024 | -26.44 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -3.54 Mn |
| Mar 31, 2024 | -3.67 Mn |
| Dec 31, 2023 | -9.17 Mn |
| Sep 30, 2023 | -46.25 Mn |
| Jun 30, 2023 | -4.62 Mn |
| Mar 31, 2023 | -8.48 Mn |
| Dec 31, 2022 | -42.09 Mn |
| Sep 30, 2022 | -6.32 Mn |
| Jun 30, 2022 | -1.82 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Sep 30, 2021 | -2.74 Mn |